AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 9360504
Drug: 17 beta-estradiol
RxNorm normalized name: 17 beta-estradiol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 17 beta-estradiol (E2; 2 mg, orally) continuously combined with dydrogesterone (5 mg)
Trial: 9360504
Drug: 17 beta-estradiol
RxNorm normalized name: 17 beta-estradiol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 17 beta-estradiol (E2; 2 mg, orally) continuously combined with dydrogesterone (10 mg)
Trial: 9360504
Drug: 17 beta-estradiol
RxNorm normalized name: 17 beta-estradiol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 17 beta-estradiol (E2; 2 mg, orally) continuously combined with dydrogesterone (15 mg)
Trial: 3900846
Drug: Vitamin E
RxNorm normalized name: Vitamin E
DrugBank: Vitamin E (DB00163)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vitamin E (5 mg/dL)
Trial: 24694337
Drug: 17β‐estradiol (0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 17β‐estradiol (0.1 mg/d via continuous delivery skin patch)
Trial: 24694337
Drug: Progesterone (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Progesterone (100 mg/d via vaginal insert)
Trial: 24694337
Drug: Testosterone (12.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Testosterone (12.5 mg/d via skin gel)
Trial: 22319034
Drug: High-calorie diet
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-calorie diet and sedentary lifestyle with prednisolone (37.5 mg once daily)
Trial: 20926001
Drug: Topical ionized
RxNorm normalized name: calcium iodized
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical ionized solution (IS)
Trial: 20926001
Drug: Topical saline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical saline solution (placebo)
Trial: 18618034
Drug: 17% carbamide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 17% carbamide peroxide gel
Trial: 9807138
Drug: 10% carbamide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10% carbamide peroxide gel
Trial: 18618034
Drug: 0% carbamide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0% carbamide peroxide gel (control group)
Trial: 12037720
Drug: Vitamin A
RxNorm normalized name: Vitamin A
DrugBank: Vitamin A (DB00162)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin A (retinol) at a dose of 50,000 IU/d for 10 days
Trial: 12037720
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg T(3) after 10 days of PL treatment
Trial: 12037720
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg T(3) after 10 days of vitamin A treatment
Trial: 10404854
Drug: Acebutolol 200
RxNorm normalized name: acebutolol 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acebutolol 200 mg once daily
Trial: 2184330
Drug: Oral immunization
RxNorm normalized name: Immune Globulin
DrugBank: Human immunoglobulin G (DB00028)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral immunization with killed Haemophilus influenzae
Trial: 7023086
Drug: Intrathecal and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrathecal and peridural injection of 0.5 ml (= 10 mg) Triamcinolone hexacetonide
Trial: 31450986
Drug: Crystalloid-based prime
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Crystalloid-based prime solution
Trial: 31450986
Drug: Erythrocyte-based prime
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erythrocyte-based prime solution (control)
Trial: 28079534
Drug: Olmesartan 20mg
RxNorm normalized name: HCTZ 12.5/OLMESARTAN 20MG TAB
DrugBank: Olmesartan (DB00275)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olmesartan 20mg once daily for 16 weeks
Trial: 28079534
Drug: Azilsartan 20mg
DrugBank: Azilsartan medoxomil (DB08822)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Azilsartan 20mg once daily for 16 weeks
Trial: 24197518
Drug: Red LED
RxNorm normalized name: acid red 35
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Red LED therapy (630 ± 10 nm)
Trial: 24197518
Drug: Infrared LED
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Infrared LED therapy (850 ± 10 nm)
Trial: 24197518
Drug: Infrared laser
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Infrared laser therapy (780 nm) - Positive control group
Trial: 12669392
Drug: Radiation therapy
RxNorm normalized name: Sensitizers used in photodynamic/radiation therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radiation therapy for malignant gliomas
Trial: 12669392
Drug: Combination chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination chemotherapy for germinoma and primary CNS lymphoma
Trial: 12669392
Drug: IMRT (Intensity-Modulated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IMRT (Intensity-Modulated Radiation Therapy)
Trial: 9296277
Drug: Innogem 300
RxNorm normalized name: Innofem
DrugBank: Estradiol (DB00783)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Innogem 300 mg capsule
Trial: 8345499
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy (10 mg nitrendipine plus 120 mg verapamil)
Trial: 8345499
Drug: Single drug
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single drug therapy (240 mg verapamil or 20 mg nitrendipine)
Trial: 3027839
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg of itraconazole per day for seven days
Trial: 20299990
Drug: Closed-loop anaesthesia
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Closed-loop anaesthesia delivery system (CLADS) with continuous infusion of propofol
Trial: 20299990
Drug: Manual administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Manual administration of propofol adjusted by clinician
Trial: 18619256
Drug: Zhi‐Xin‐Fang combined
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zhi‐Xin‐Fang combined with standard western medicines
Trial: 18619256
Drug: Standard western
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard western medical therapy
Trial: 15150185
Drug: Ertapenem 1
RxNorm normalized name: ertapenem 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ertapenem 1 g once a day
Trial: 11440287
Drug: Ezetimibe 20
RxNorm normalized name: atorvastatin-ezetimibe 20 mg-10 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ezetimibe 20 mg
Trial: 11440287
Drug: Ezetimibe (both
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ezetimibe (both doses)
Trial: 8016771
Drug: Inhaled frusemide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled frusemide (40 mg)
Trial: 7828692
Drug: Inhaled lysine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled lysine acetylsalicylate (modified protocol)
Trial: 23054350
Drug: Ecologically‐Based Family
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ecologically‐Based Family Therapy (EBFT)
Trial: 12908663
Drug: Atypical antipsychotics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atypical antipsychotics (2000 estimates)
Trial: 2880755
Drug: Cefuroxime 1.5
RxNorm normalized name: cefuroxime 1.5 GM Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefuroxime 1.5 g every 8th hour for 24 hours followed by cefadroxil 0.5 g twice daily for 6 days
Trial: 2880755
Drug: Cefuroxime and
RxNorm normalized name: cefuroxime and metronidazole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefuroxime and cefadroxil (treatment)
Trial: 24405007
Drug: Behavioral treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Behavioral treatment intervention using a handheld, vibrating stimulation device
Trial: 22968527
Drug: Tranexamic acid
RxNorm normalized name: Tranexamic Acid
DrugBank: Tranexamic acid (DB00302)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tranexamic acid (1 g over 10 minutes followed by 1 g over eight hours)
Trial: 15264116
Drug: Lamivudine 100
RxNorm normalized name: lamivudine 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lamivudine 100 mg/day for 12 weeks
Trial: 12271297
Drug: AE-941 at
RxNorm normalized name: AT-III
DrugBank: Antithrombin III human (DB11598)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AE-941 at 240 mL/d
Trial: 12271297
Drug: AE-941 at
RxNorm normalized name: AT-III
DrugBank: Antithrombin III human (DB11598)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AE-941 at 120 mL/d
Trial: 12271297
Drug: AE-941 at
RxNorm normalized name: AT-III
DrugBank: Antithrombin III human (DB11598)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AE-941 at 60 mL/d
Trial: 12271297
Drug: AE-941 at
RxNorm normalized name: AT-III
DrugBank: Antithrombin III human (DB11598)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AE-941 at 30 mL/d
Trial: 12271297
Drug: AE-941 (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AE-941 (all doses)
Trial: 12271297
Drug: Nonserious drug-related
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonserious drug-related adverse events
Trial: 7911530
Drug: Celiprolol (0.15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Celiprolol (0.15 mg/kg, intravenous)
Trial: 7911530
Drug: Metoprolol (intravenous)
DrugBank: Metoprolol (DB00264)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Metoprolol (intravenous)
Trial: 30965344
Drug: Dexamethasone 25
RxNorm normalized name: dexamethasone 25 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone 25 mg/m2 daily for 4 days, repeated every 28 days over 32 weeks (first trial)
Trial: 30965344
Drug: Dexamethasone 50
RxNorm normalized name: Dexamethasone 500 microgram oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone 50 mg/m2 every 4 weeks for 12 weeks, followed by 25 mg/m2 every 4 weeks for 36 weeks (second trial)
Trial: 14518142
Drug: Lactobacillus casei
RxNorm normalized name: Lactobacillus Casei
DrugBank: Lactobacillus casei (DB16541)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lactobacillus casei and Lactobacillus acidophilus (10(10)-10(12) CFU/g)
Trial: 14518142
Drug: Saccharomyces boulardii
RxNorm normalized name: Saccharomyces boulardii
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saccharomyces boulardii (10(10)-10(12) CFU/g)
Trial: 16881093
Drug: Arthroscopic synovectomy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Arthroscopic synovectomy (AS) followed by intraarticular corticosteroid (IAC) treatment
Trial: 10677890
Drug: Nebulized anaesthetics
RxNorm normalized name: Gelato Anesthetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nebulized anaesthetics (10 ml of 1% trimecain)
Trial: 10677890
Drug: Isotonic chlorine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isotonic chlorine solution
Trial: 1837260
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg etodolac twice daily for 12 weeks
Trial: 1837260
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg piroxicam once daily for 12 weeks
Trial: 7060822
Drug: 2% miconazole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2% miconazole nitrate aerosol spray powder
Trial: 7060822
Drug: 1% tolnaftate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1% tolnaftate aerosol spray powder
Trial: 28927706
Drug: Evolocumab (140
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Evolocumab (140 mg every 2 weeks or 420 mg once per month)
Trial: 25562510
Drug: Functional incidental
RxNorm normalized name: plasma protein fraction Injection [Plasmanate]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Functional incidental training (FIT) program consisting of 4 extra episodes of functional exercise daily during SSR
Trial: 24673819
Drug: Intravenous silibinin
RxNorm normalized name: Silibinin
DrugBank: Silibinin (DB09298)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous silibinin (20 mg/kg daily for 14 days)
Trial: 17071000
Drug: Cognitive-behavioral therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-behavioral therapy (CBT) for chronic pain, specific details on dosage and duration not available.
Trial: 11588683
Drug: Group 1
RxNorm normalized name: Chlamydophila psittaci biogroup 1 Ab
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group 1 (123 ml of 300 mgl/ml)
Trial: 11588683
Drug: Group 2
RxNorm normalized name: Chlamydophila psittaci biogroup 2 Ab
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group 2 (112 ml of 335 mgl/ml)
Trial: 11588683
Drug: Group 3
RxNorm normalized name: Chlamydophila psittaci biogroup 3 Ab
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group 3 (100 ml of 370 mgl/ml)
Trial: 9540151
Drug: 30 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg/kg propacetamol
Trial: 9540151
Drug: 0.2 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.2 mg/kg morphine
Trial: 8022626
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of low-dose morphine (2 mg) and bupivacaine (25 mg)
Trial: 8022626
Drug: All treatments
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All treatments (Combination, Bupivacaine, Morphine)
Trial: 2645916
Drug: Glucose (1
RxNorm normalized name: Fludeoxyglucose (18F)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Glucose (1 mg/kg po)
Trial: 30882242
Drug: Pro II
RxNorm normalized name: Climara Pro
DrugBank: Estradiol (DB00783)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pro II (a capsule containing 3 strains, 109 cfu per strain)
Trial: 30882242
Drug: Pro I
RxNorm normalized name: Cipro I.V.
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pro I (a capsule containing 3 strains, 109 cfu per strain)
Trial: 31152911
Drug: Revefenacin 88
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Revefenacin 88 μg
Trial: 28987804
Drug: Revefenacin 350
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Revefenacin 350 μg
Trial: 29096627
Drug: Revefenacin ≥88
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Revefenacin ≥88 μg
Trial: 21242072
Drug: C. laevigata
FDA approved: no
EMA approved: no
PMDA approved: no
Description: C. laevigata (400 mg three times a day)
Trial: 20205984
Drug: 60 mg
RxNorm normalized name: opium 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 mg isoflavones
Trial: 17919059
Drug: Bur treatment
RxNorm normalized name: bur oak pollen extract
DrugBank: Quercus macrocarpa pollen (DB10738)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bur treatment (Intensive bur FG 40D4)
Trial: 7762909
Drug: Ganciclovir, 2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ganciclovir, 2.5 mg/kg body weight administered intravenously on every day that antilymphocyte antibody therapy was administered
Trial: 7762909
Drug: No anticytomegalovirus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No anticytomegalovirus therapy
Trial: 2306420
Drug: Propranolol 160
RxNorm normalized name: propranolol 160 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol 160 mg HCl for 4 days
Trial: 30590600
Drug: Uninterrupted (UI)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Uninterrupted (UI) non-vitamin K antagonist oral anticoagulants (NOACs)
Trial: 30590600
Drug: Single-dose skipped
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-dose skipped (SDS) NOACs
Trial: 25754330
Drug: Tildrakizumab 3
RxNorm normalized name: Tildrakizumab
DrugBank: Tildrakizumab (DB14004)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Tildrakizumab 3 mg/kg
Trial: 25754330
Drug: Tildrakizumab 10
RxNorm normalized name: tildrakizumab 100 mg/mL subcutaneous solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tildrakizumab 10 mg/kg
Trial: 25754330
Drug: Tildrakizumab 3
RxNorm normalized name: Tildrakizumab
DrugBank: Tildrakizumab (DB14004)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Tildrakizumab 3 mg/kg and 10 mg/kg (pooled)
Trial: 22848074
Drug: Nitroglycerin (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitroglycerin (200 µg via ipsilateral peripheral vein about 3 min before puncture)
Trial: 11249725
Drug: BLP-25 vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BLP-25 vaccine with IL-2 in a liposomal delivery system
Trial: 3481508
Drug: Intra-amniotic PGF2
RxNorm normalized name: amniotic fluid (bovine)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intra-amniotic PGF2 alpha 40 mg followed by oxytocin stimulation
Trial: 3481508
Drug: Intracervical PGE2
RxNorm normalized name: PGE2
DrugBank: Dinoprostone (DB00917)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intracervical PGE2 1.0 mg in gel for 4 h followed by intra-amniotic PGF2 alpha 40 mg
Trial: 3481508
Drug: Intracervical PGE2
RxNorm normalized name: PGE2
DrugBank: Dinoprostone (DB00917)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intracervical PGE2 1.0 mg in gel
Trial: 26850877
Drug: Intravenous (IV)
RxNorm normalized name: intravenous (IV) infusion pump
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous (IV) dexmedetomidine (1.0 μg/kg)
Trial: 26850877
Drug: Intranasal (IN)
RxNorm normalized name: influenza A virus (H1N1) antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal (IN) dexmedetomidine (1.5 μg/kg)
Trial: 18184543
Drug: Western medicine
RxNorm normalized name: Medicaine Sting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Western medicine (WM) therapy including voltaren extended action tablet, methotrexate, and sulfasalazine
Trial: 18184543
Drug: Traditional Chinese
RxNorm normalized name: BORNEOL 1 g in 6.5 g / MINT 1 g in 6.5 g / ANGELICA DAHURICA ROOT 0.5 g in 6.5 g TOPICAL POWDER [Traditional Chinese Medicine Health Card and TCM Epidemic Prevention Card]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Traditional Chinese medicine (CM) therapy including glucosidorum Tripterygll totorum tablet and Yishen Juanbi Tablet
Trial: 15250433
Drug: Venlafaxine (maximum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Venlafaxine (maximum tolerated dose, 75 mg in most cases)
Trial: 9717594
Drug: 5 IU
RxNorm normalized name: Vitamin E 15 IU/0.3 ML Oral Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 IU oxytocin i.v. and 2 ml saline imy
Trial: 9717594
Drug: 20 IU
RxNorm normalized name: Calcium/Phosphorus/Vitamin D 105 MG-81 MG-120 IU Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 IU oxytocin into the myometrium and 0.5 ml saline i.v.
Trial: 8628581
Drug: Ketamine (mean
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamine (mean dose: 32 mg)
Trial: 8628581
Drug: Alfentanil (mean
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alfentanil (mean dose: 3075 micrograms)
Trial: 2501394
Drug: Mupirocin (Bactroban)
RxNorm normalized name: Mupirocin
DrugBank: Mupirocin (DB00410)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mupirocin (Bactroban) ointment applied twice daily for 7 days
Trial: 2501394
Drug: Sodium fusidate
RxNorm normalized name: Sodium fusidate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sodium fusidate (Fucidin) ointment applied thrice daily for 7 days
Trial: 353089
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg phenobarbital plus 8 mg belladonna (P & B)
Trial: 31676719
Drug: Home-based care
RxNorm normalized name: Gelato Home-Care 1.1 % Toothpaste
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Home-based care from patient-nominated lay people trained to deliver intramuscular streptomycin.
Trial: 24706006
Drug: Methotrexate (initial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methotrexate (initial treatment), followed by either sulfasalazine+hydroxychloroquine or infliximab for non-responders.
Trial: 21785396
Drug: Budesonide 0.25
RxNorm normalized name: budesonide 0.25 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Budesonide 0.25 mg/g cream in the morning and tacalcitol 4 µg/g ointment in the evening
Trial: 21785396
Drug: Calcipotriol 50
RxNorm normalized name: Calcipotriol 50 microgram/g cutaneous cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcipotriol 50 µg/g plus betamethasone dipropionate 0.5 mg/g ointment once daily
Trial: 26669417
Drug: Music therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Music therapy (20 minutes)
Trial: 16699359
Drug: Music therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Music therapy and Control
Trial: 15567701
Drug: Heavy derivative
RxNorm normalized name: heavy mineral oil
DrugBank: Mineral oil (DB11057)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heavy derivative PD control approach for insulin infusion
Trial: 15567701
Drug: Modelled insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Modelled insulin infused
Trial: 11699800
Drug: Immediate-release dextroamphetamine
RxNorm normalized name: dextroamphetamine Extended Release Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate-release dextroamphetamine sulfate
Trial: 11699800
Drug: Immediate-release amphetamines
RxNorm normalized name: amphetamine Extended Release Suspension
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate-release amphetamines
Trial: 7624642
Drug: Conventional fractionated
RxNorm normalized name: LIVER FRACTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional fractionated radiation therapy (20 and 45 Gy delivered in 10 and 15 fractions)
Trial: 7624642
Drug: Conventional fractionated
RxNorm normalized name: LIVER FRACTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional fractionated radiation therapy
Trial: 3688637
Drug: Indomethacin (Indocin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomethacin (Indocin SR 75 mg every 12 h for 5 days)
Trial: 28401441
Drug: Inpatient multicomponent
RxNorm normalized name: Impatiens irvingii whole extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inpatient multicomponent occupational rehabilitation (4+4 days) including Acceptance and Commitment Therapy (ACT), physical training, and work-related problem-solving.